Neoadjuvant chemotherapy before fertility-sparing surgery may improve pregnancy rates in early cervical cancer
Fertility-sparing cervical cancer treatment shows higher pregnancy rate with chemotherapy first
A meta-analysis of 1,453 women with early-stage cervical cancer (FIGO 2018 IB2-IIA1; tumours ≥2 cm) found neoadjuvant chemotherapy followed …
Women with early cervical cancer tumors larger than 2 centimeters had a higher pregnancy rate after chemotherapy before surgery compared to …
Autologous ovarian grafting may preserve ovarian function in young cervical cancer patients undergoing pelvic radiotherapy
Small trial tests ovarian tissue graft to protect hormone function during cervical cancer radiation
An exploratory phase II randomized trial of 22 women aged ≤35 years with locally advanced cervical cancer found that at six months, 85% of p…
A new trial shows grafting ovarian tissue before cervical cancer radiation kept 85% of young patients' hormone levels normal and prevented e…
Home test kits may boost cervical cancer screening, but evidence details are lacking
Can a home test kit help more women get screened for cervical cancer?
A review of article headlines suggests home test kits may increase cervical cancer screening, but no study details, methodology, or results …
Home test kits appear to boost cervical cancer screening rates by offering a private, convenient way for women to take control of their heal…
California's COVID-19 stay-at-home order associated with affected cervical cancer screening rates
Did pandemic lockdowns cause women to miss cervical cancer screenings?
An observational report from a large Southern California health system found that cervical cancer screening rates for women aged 21-65 were …
California's pandemic lockdowns likely caused women to miss cervical cancer screenings, delaying early detection of pre-cancerous changes.
Pembrolizumab ranks highest for survival in cervical cancer network meta-analysis
Review finds pembrolizumab may improve survival in advanced cervical cancer
A Bayesian network meta-analysis of phase 3 RCTs compared immune checkpoint inhibitors in locally advanced and metastatic cervical cancer. P…
Adding pembrolizumab to standard treatment for advanced cervical cancer is linked to better survival and longer time before the disease prog…
Low sADC Predicts Poor Outcomes in Cervical Cancer with PD-1 Inhibitors
Can imaging predict how well cervical cancer patients respond to treatment?
In a study of 167 cervical cancer patients, lower substantial ADC (sADC) correlated with worse PFS (HR=1.81, P=0.005) and OS (HR=2.40, P=0.0…
Low water movement in cervical cancer tumors on scans predicts worse survival when patients take immunotherapy, helping doctors choose bette…
Triapine Added to Cisplatin and Radiation for Cervical/Vaginal Cancer: Phase III Results
Could a new drug boost survival for women with advanced cervical and vaginal cancers?
Phase III trial evaluates triapine with cisplatin and radiation vs. standard treatment for advanced cervical and vaginal cancers.
A new drug called triapine may help women with advanced cervical and vaginal cancers live longer when added to standard radiation and chemot…